Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program

Pilot study for assessing the effectiveness of a Navigator program to aid in clinical trial participation amongst the Chinese demographic

Stanford is currently not accepting patients for this trial.

Stanford Investigator(s):

Intervention(s):

  • behavioral: Navigator Support

Eligibility


Inclusion Criteria:

Cancer patients for Focus Group must meet the following criterion:

   - diagnosis of any gynecologic or breast cancer and be pursuing treatment here at
   Stanford within the last 2 years

   - must read and speak Chinese

   - willing and able to participant in group discussions

Cancer patients to receive Navigator Support must meet the following criterion:

   - Newly diagnosed with gynecologic or breast cancer -pursuing treatment at Stanford
   Cancer Center

   - must read and speak Chinese

   - willing and able to have an individual relationship with a Navigator

Health Professional must meet the following criterion:

-must currently work in the Stanford gynecologic Oncology Clinic

Navigators must meet the following criterion:

   - Chinese and English speaking

   - willing and able to participate in training and to serve as a Navigator

   - preferably a Cancer survivor

Exclusion Criteria:

Cancer patients must have a GOG performance status of 0-2 (see attached document for
further details). Focus Group participate MAY be able to be participating in another study
but patients who are already participating in a clinical trial will not be assigned a
Navigator.

No Exclusionary criterion for Health Professionals or Navigators.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Mei-Chin Kuo
6507361977
Not Recruiting

Our research team includes physicians, residents, medical students, research assistants, and volunteers. Our research topics include medical imaging, device validation,  mobile application development, and pharmaceutical trials.  

Some of the Neuro-Opthalmic concerns we investigate include Multiple Sclerosis, Optic Neuritis, IIH, and ICP.